{"prompt": "['Date: June 30, 2020', 'Version: 8.0', 'Page: 51 of 52', 'Yes, hot flashes', 'Yes, night sweats', 'Yes, vaginal dryness', 'Have you had a hysterectomy?', 'If yes, what type of operation did you have?', 'Uterus', 'Uterus + one ovary', 'Uterus + both ovaries', '14. References', '1. Cash B, Sullivan S, Barghout V. Total costs of IBS: employer and managed care perspective. Am J', 'Manag Care. Apr 2005; 11(1 Suppl):S7-16.', '2. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel', 'syndrome. Gastroenterol. Dec 2002;123(6):2108-2131.', '3. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel', 'syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. Mar', '2003;17(5):643-650.', '4. Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J', 'Gastrointestin Liver Dis. Sep 2006;15(3):237-241.', '5. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An evidence-based position statement on the', 'management of irritable bowel syndrome. Am J Gastroenterol. Jan 2009;104(Suppl 1):S1-35.', '6. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd Epidemiology of colonic symptoms and the', 'irritable bowel syndrome. Gastroenterol. Oct 1991;101(4):927-934.', '7. Pimentel M, Gunsalus RP, Rao SSC, Zhang H. Methanogens in human health and disease. Am J', 'Gastroenterol. Jul 2012;1(1) Suppl:28-33.', '8. Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose', 'breath test is associated with gastrointestinal disease presentation. Dig Dis Sci. Jan', '2003;48(1):86-92.', '9. Kunkel D, Basseri RJ, Makhani MD, Chong K, Chang C, Pimentel M. Methane on breath testing is', 'associated with constipation: a systematic review and meta-analysis. Dig Dis Sci. 2011', 'Jun;56(6):1612-8.', '10. Furnari M, Savarino E, Bruzzone L, Moscatelli A, Gemignani L, Giannini EG, Zentilin P, Dulbecco P,', 'Savarino V. Reassessment of the role of methane production between irritable bowel syndrome', 'and functional constipation. J Gastrointestin Liver Dis. 2012 Jun;21(2):157-63.', '11. Ghoshal U, Shukla R, Srivastava D, Ghoshal UC. Irritable Bowel Syndrome, particularly the', 'constipation-predominant form, involves an increase in Methanobrevibacter smithii, which is', 'associated with higher methane production. Gut Liver. 2016 Nov 5;10(6):932-938.', '12. Lee KM, Paik CN, Chung WC, Yang JM, Choi MG. Breath methane positivity is more common and', 'higher in patients with objectively proven delayed transit constipation. Eur J Gastroenterol', 'Hepatol. 2013 Jun;25(6):726-32.', '13. Suri J, Kataria R, Malik Z, Parkman HP, Schey R. Elevated methane levels in small intestinal', 'bacterial overgrowth suggests delayed small bowel and colonic transit. Medicine (Baltimore).', '2018 May;97(21):e10554.']['Date: June 30, 2020', 'Version: 8.0', 'Page: 52 of 52', '14. Chang BW, Rezaie A. Irritable Bowel Syndrome-Like Symptoms Following Fecal Microbiota', 'Transplantation: A Possible Donor-Dependent Complication. Am J Gastroenterol. 2017', 'Jan;112(1):186-187.', '15. Park YM, Lee YJ, Hussain Z, Lee YH, Park H. The effects and mechanism of action of methane on', 'ileal motor function. Neurogastroenterol Motil. 2017 Sep;29(9). doi: 10.1111/nmo.13077', '16. Pimentel M, Lin HC, Enayati P, van den Burg B, Lee HR, Chen JH, Park S, Kong Y, Conklin J.', 'Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small', 'intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1089-95', '17. Jahng J, Jung IS, Choi EJ, Conklin JL, Park H. The effects of methane and hydrogen gases produced', 'by enteric bacteria on ileal motility and colonic transit time. Neurogastroenterol Motil. 2012', 'Feb;24(2):185-90,e92.', '18. Mevacor\u00ae (lovastatin) tablets. Prescribing information, 2014. Merk & Co., Inc., Whitehouse', 'Station, NJ 08889, USA.', '19. Duggan DE, Chen IW, Bayne WF, Halpin RA, Duncan CA, Schwartz MS, Stubbs RJ, Vickers S. The', 'physiological disposition of lovastatin. Drug Metab Dispos. 1989 Mar-Apr;17(2):166-73', '20. Marsh E, Morales W, Chua KS, Marsh Z, Weitsman S, Wacher V, Kim JH, Pimentel, M. (2015)', '[Abstract 1771] Lovastatin lactone inhibits methane production in human stool homogenates.', 'Am J Gastroenterol. 110 (Suppl. 1): S753.', '21. Morales W, Marsh E, Yu A, Marsh Z, Weitsman S, Barlow GM, Rezaie A, Chang C, Wacher V,', 'Pimentel, M. (2015) [Abstract Mo 2051] Lovastatin improves stool form in Methanobrevibacter', 'smithii colonized rats with constipation. Gastroenterology 148 (Suppl. 1): S-779-80.', '22. Gottlieb K, Wacher V, Sliman J, Coughlin O, McFall H, Rezaie A, Pimentel M. (2016) [Abstract', 'Su1210] SYN-010, a proprietary modified-release formulation of lovastatin lactone, lowered', 'breath methane and improved stool frequency in patients with IBS-C: results of a multi-center', 'randomized double-blind, placebo-controlled Phase 2a trial. Gastroenterology 150 (Suppl. 1):', 'S496-7.', '23. Wacher V, Gottlieb K, Sliman J, Coughlin O, Kokai-Kun, J, McFall H, Pimentel M (2016) [Abstract', '562] SYN-010 modified-release lovastatin does not significantly alter lipid parameters at doses', 'that reduce methane and alleviate symptoms in patients suffering irritable bowel syndrome with', 'constipation (IBS-C). Am J Gastroenterol. 111 (Suppl. 1): S256.', '24. Hubert S, Chadwick A, Wacher V, Coughlin O, Kokai-Kun J, Bristol A. Development of a modified-', 'release formulation of lovastatin targeted to intestinal methanogens implicated in Irritable Bowel', 'Syndrome with constipation. J Pharm Sci. 2018 Feb;107(2):662-671.', '25. Muskal SM, Sliman J, Kokai-Kun J, Pimentel M, Wacher V, Gottlieb K. Lovastatin lactone may', 'improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal', 'methanogenesis pathway. Version 3. F1000Res. 2016 Apr 8 [revised 2016 Jan 1];5:606.', '26. Camilleri M, Lembo AJ, Lavins BJ, MacDougall JE, Carson RT, Williams VS, Nelson LM, Shiff SJ,', 'Currie MG, Kurtz CB, Johnston JM. Comparison of adequate relief with symptom, global, and', 'responder endpoints in linaclotide phase 3 trials in IBS-C. United European gastroenterology', 'journal. 2015 Feb ;3(1):53-62.', '27. Passos MC, Lembo AJ, Conboy LA, Kaptchuk TJ, Kelly JM, Quilty MT, Kerr CE, Jacobson EE, Hu R,', 'Friedlander E, Drossman DA. Adequate relief in a treatment trial with IBS patients: a prospective', 'assessment. Am J Gastroenterol. 2009 Apr 1;104(4):912-9.', '28. Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel disorders.', 'Gastroenterology. 2016 May;150(6):1393-1407.e5.']\n\n###\n\n", "completion": "END"}